New treatment approach improves survival, reduces recurrence risk in muscle-invasive bladder cancer

Researchers have found that a combination of enfortumab vedotin and pembrolizumab helps patients with muscle-invasive bladder ...

Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

It is expected that the European Commission will grant the Marketing Authorisation by the end of September 2026.